Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
BMS 690514 is a pan-inhibitor of HER and VEGFR family kinases (IC50s = 5, 19, 60, 50, 50, and 25 nM for EGFR, HER2, HER4, VEGFR1, VEGFR2, and VEGFR3, respectively).1 It is selective for these kinases over 11 additional kinases but also inhibits FMS-related tyrosine kinase 3 (FLT3), calcium/calmodulin-dependent protein kinase II (CAMKII), LCK, and PKA (IC50s = 110, 170, 220, and 280 nM, respectively). BMS 690514 selectively inhibits the proliferation of cancer cells containing EGFR gene amplifications or mutations and HER2 gene amplifications over those expressing wild-type EGFR or not expressing EGFR and HER2. It inhibits tumor growth and angiogenesis in an L2987 lung cancer mouse xenograft model when administered at a dose of 90 mg/kg.
WARNING This product is not for human or veterinary use.
1. Antitumor and antiangiogenic activities of BMS-